Reduction of elevated tumor necrosis factor (TNF)-alpha levels after infliximab treatment does not predict treatment response in patients with rheumatoid arthritis (RA), according to a report in the November issue of The Journal of Rheumatology. Reuters Health Information
Review treatment decisions in patients with RA during the initial diagnosis; in patients who have inadequate response to maximal disease-modifying antirheumatic drugs; and treatment failures.
Tocilizumab, a novel IL-6R inhibitor, may be beneficial for the treatment of RA in patients who do not respond to methotrexate or disease-modifying antirheumatic drugs. American Journal of Health-System Pharmacy
An expert panel discusses 3 areas of cultural competence -- bias, language barriers, and communication -- in the context of clinician-patient vignettes. Medscape Internal Medicine
